Thus, we analyzed p-AKT, CIP2A, phosphorylated H3 (p-H3), and cleaved Caspase 3 (c-casp3) levels in 25 fresh breast cancer specimens with different molecular subtypes treatedex vivowith doxorubicin. The gene discussed is CIP2A; the disease is breast cancer.